HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caroline Germa Selected Research

neratinib

11/2014Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
12/2013A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caroline Germa Research Topics

Disease

7Breast Neoplasms (Breast Cancer)
02/2018 - 12/2013
4Neoplasms (Cancer)
01/2020 - 10/2003
3Disease Progression
01/2020 - 01/2018
2Diarrhea
01/2018 - 11/2014
2Neutropenia
01/2018 - 11/2016
1Alopecia (Baldness)
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Vomiting
01/2018
1Anemia
01/2018
1Fatigue
01/2018
1Nausea
01/2018
1Leukopenia
11/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2005

Drug/Important Bio-Agent (IBA)

5ribociclibIBA
02/2018 - 11/2016
4Letrozole (Femara)FDA LinkGeneric
02/2018 - 11/2016
3Hormones (Hormone)IBA
01/2018 - 11/2016
2Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2018 - 11/2016
2human ERBB2 proteinIBA
11/2016 - 11/2014
2Lapatinib (GW572016)FDA Link
11/2014 - 12/2013
2neratinibIBA
11/2014 - 12/2013
2Capecitabine (Xeloda)FDA Link
11/2014 - 12/2013
2Trastuzumab (Herceptin)FDA Link
11/2014 - 12/2013
1durvalumabIBA
01/2020
1Cyclin-Dependent Kinase 4IBA
01/2018
1Aromatase InhibitorsIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2016
1AlpelisibIBA
01/2016
1NVP-BKM120IBA
01/2016
1MTOR InhibitorsIBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
11/2014
1Tyrosine Kinase InhibitorsIBA
11/2014
1Pharmaceutical PreparationsIBA
11/2014
1Epidermal Growth Factor (EGF)IBA
12/2013
1GemcitabineFDA Link
03/2005
1Irinotecan (Camptosar)FDA LinkGeneric
10/2003

Therapy/Procedure

7Therapeutics
01/2020 - 12/2013
1Retreatment
01/2020
1Aftercare (After-Treatment)
01/2018
1Drug Therapy (Chemotherapy)
03/2005
1Intravenous Infusions
10/2003